Nasal provocation with allergen induces a secondary serum IgE antibody response

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 4, 1997, Pages 505-510

  Naclerio, Robert M ^a,b   Adkinson Jr , N Franklin ^a   Moylan, Birgitta ^a   Baroody, Fuad M ^a   Proud, David ^a   Kagey Sobotka, Anne ^a   Lichtenstein, Lawrence M ^a   Hamilton, Robert ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Allergic rhinitis; Antigen; Beclomethasone; Human; IgE; Nasal challenge

Indexed keywords

BECLOMETASONE DIPROPIONATE; IMMUNOGLOBULIN E ANTIBODY; RAGWEED ANTIGEN;

ALLERGIC RHINITIS; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTRANASAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0030827931     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70143-X     Document Type: Article

References (20)

1. Gleich JG, Zimmermann BS, Henderson LL, Yunginger JW. Effects of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. J Allergy Clin Immunol 1982;70:261-71.
2. Lichtenstein LM, Ishizaka K, Norman PS, Sobotka AK, Hill BM. IgE antibody measurement in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest 1973;52:472-82.
3. Naclerio RM, Adkinson NF Jr, Creticos PS, Baroody FM, Hamilton RG, Norman PS. Intranasal steroids inhibit seasonal increases in ragweed-specific IgE antibodies. J Allergy Clin Immunol 1993;92:717-21.
4. Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF Jr, Meyers DA, Norman PS, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
5. Watase T, Okuda M. The effects of autonomotropic drugs on allergic nasal mucosa. Rhinology 1986;24:181-6.
6. Svensson C, Pipkorn U, Alkner U, Baumgarten CR, Persson CG. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy 1992;22:411-6.
7. Majchel AM, Baroody F, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effect of oxymetazoline on the early response to nasal challenge with antigen. J Allergy Clin Immunol 1993;92:767-70.
8. Siraganian R. An automated continuous flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 1974;57:383-94.
9. Imanari T, Kaizu T, Yoshida H, Yates KN, Pierce JV, Pisano JJ. Radiochemical assays for human urinary, salivary and plasma kallikreins. In: Pisano JJ, Austen KF, editors. Washington (DC): Department of Health, Education, and Welfare: 1986. p. 205-13. DHEW Pub. No (NIH) 76-791.
10. Baumgarten CR, Nichols RC, Naclerio RM, Lichtenstein LM, Norman PS, Proud D. Plasma kallikrein during experimentally-induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol 1986;137:977-82.
11. Baumgarten CR, Nichols RC, Naclerio RM, Proud D. Concentrations of glandular kallikrein in human nasal secretions during experimentally-induced allergic rhinitis. J Immunol 1986;137:1323-8.
12. Hamilton RG, Adkinson NF Jr. Measurement of total serum immunoglobulin E and allergen-specific immunoglobulin E antibody. In: Rose N, de Macario EC, Fahey JL, Friedman H, Penn GM, editors. Manual of clinical immunology. Washington (DC): American Society for Microbiology; 1992. p. 689-701.
13. Butler JE, Hamilton RG. Quantitation of specific antibodies: methods of expression, standards solid-phase considerations and specific applications. In: Butler JE, editor. Immunochemistry of solid phase immunoassays. Boca Raton (FL): CRC Press; 1991. p. 173-98.
14. Iliopoulos O, Proud D, Adkinson NF Jr, Norman PS, Kagey-Sobotka A, Lichtenstein LM, et al. Relationship between the early, late and rechallenge reaction to nasal challenge with antigen. Observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol 1990;86:851-61.
15. Nickelsen J, Goldstein S, Mueller U, Wypych J, Reisman R, Arbesman C. Local intranasal immunotherapy for ragweed allergic rhinitis. J Allergy Clin Immunol 1981;68:41-5.
16. Marsh DE. Allergens and the genetics of allergy. In: Sela M, editor. The antigens. Vol 3. New York: Academic Press, 1975. p. 271-359.
17. Smith J. Epidemiology and natural history of asthma, allergic rhinitis and atopic dermatitis (eczema). In: Middleton E, Reed C, Ellis E, Adkinson NF Jr, Yunginger JW, editors. Allergy: principles and practice. St. Louis: CV Mosby; 1988. p. 891-929.
18. Georgitis J, Nickelsen J, Wypych J, Kane J, Reisman R. Local nasal immunotherapy. J Allergy Clin Immunol 1985;75:496-500.
19. Schleimer RP. Glucocorticosteroids. In: Middleton E, Reed C, Ellis E, Adkinson NF Jr, Yunginger JW, editors. Allergy: principles and practice. St. Louis: CV Mosby; 1988. p. 739-65.
20. + subsets. J Immunol 1995;155:3322-8.